Amneal Pharmaceuticals, Class Stock Analysis

Amneal Stock Analysis Notes

About 49.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 230.5. Amneal Pharmaceuticals, recorded a loss per share of 0.38. The entity had not issued any dividends in recent years. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey. Amneal Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 7000 people. For more info on Amneal Pharmaceuticals, Class please contact Chintu Patel at 908 947 3120 or go to https://www.amneal.com.

Amneal Pharmaceuticals, Investment Alerts

Amneal Pharmaceuticals, Upcoming and Recent Events

Amneal Largest EPS Surprises

View All Earnings Estimates

Amneal Pharmaceuticals, Environmental, Social, and Governance (ESG) Scores

Amneal Stock Institutional Investors

Note, although Amneal Pharmaceuticals,'s institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amneal Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.89 B.

Amneal Profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11.

Management Efficiency

Amneal Pharmaceuticals, has return on total asset (ROA) of 0.0624 % which means that it generated a profit of $0.0624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.8126) %, meaning that it created substantial loss on money invested by shareholders. Amneal Pharmaceuticals,'s management efficiency ratios could be used to measure how well Amneal Pharmaceuticals, manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Amneal Pharmaceuticals,'s Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 1.12 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.05). At this time, Amneal Pharmaceuticals,'s Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 63.1 M in 2025, whereas Total Assets are likely to drop slightly above 3.2 B in 2025.

Technical Drivers

As of the 28th of March, Amneal Pharmaceuticals, shows the Mean Deviation of 1.51, risk adjusted performance of 0.0553, and Downside Deviation of 1.9. Amneal Pharmaceuticals, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Amneal Pharmaceuticals, Price Movement Analysis

Amneal Pharmaceuticals, Insider Trading Activities

Amneal Pharmaceuticals, Outstanding Bonds

Amneal Pharmaceuticals, Predictive Daily Indicators

Amneal Pharmaceuticals, Corporate Filings

Amneal Pharmaceuticals, Forecast Models

Amneal Pharmaceuticals,'s time-series forecasting models are one of many Amneal Pharmaceuticals,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amneal Pharmaceuticals,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amneal Pharmaceuticals, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amneal shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amneal Pharmaceuticals,. By using and applying Amneal Stock analysis, traders can create a robust methodology for identifying Amneal entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amneal analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amneal analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Amneal Pharmaceuticals, Class stock analysis indicators help investors evaluate how Amneal Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amneal Pharmaceuticals, shares will generate the highest return on investment. By understating and applying Amneal Pharmaceuticals, stock analysis, traders can identify Amneal Pharmaceuticals, position entry and exit signals to maximize returns.

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.